Kashiv BioSciences
Innovative drug delivery technologies and affordable biosimilars enhancing patient care globally.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
* | $150m | Debt | |
| Total Funding | 000k | ||
Related Content
Kashiv Biosciences is a fully integrated biopharmaceutical company that focuses on developing and manufacturing both small and large molecules. The company operates in the global healthcare market, offering advanced drug delivery technologies, biosimilars, and specialty pharmaceutical products. Kashiv serves a diverse range of clients including strategic partners, physicians, and patients worldwide. The business model revolves around identifying unmet medical needs in various therapeutic areas and developing clinically differentiated products to address these needs. Revenue is generated through the development and commercialization of these innovative solutions, which aim to provide effective, safe, and affordable medicines. Kashiv's commitment to patient-focused innovation is supported by state-of-the-art facilities and a workforce empowered to meet the demands of the rapidly evolving biopharmaceutical market.
Keywords: biopharmaceutical, drug delivery, biosimilars, specialty pharmaceuticals, innovation, patient care, global healthcare, unmet medical needs, clinical differentiation, affordable medicines.